Global Ranibizumab Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Ranibizumab will have significant change from previous year. According to our latest study, the global Ranibizumab market size is USD million in 2022 from USD 3374.6 million in 2021, with a change of % between 2021 and 2022. The global Ranibizumab market size will reach USD 1580.5 million in 2028, growing at a CAGR of -10.3% over the analysis period.
The United States Ranibizumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ranibizumab market, reaching US$ million by the year 2028. As for the Europe Ranibizumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ranibizumab players cover Roche, Novartis, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ranibizumab market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Glass Vial
Prefilled Syringe
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Wet AMD
Complications of Diabetes
RVO
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Novartis
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ranibizumab Market Size 2017-2028
2.1.2 Ranibizumab Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Ranibizumab Segment by Type
2.2.1 Glass Vial
2.2.2 Prefilled Syringe
2.3 Ranibizumab Market Size by Type
2.3.1 Ranibizumab Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Ranibizumab Market Size Market Share by Type (2017-2022)
2.4 Ranibizumab Segment by Application
2.4.1 Wet AMD
2.4.2 Complications of Diabetes
2.4.3 RVO
2.4.4 Others
2.5 Ranibizumab Market Size by Application
2.5.1 Ranibizumab Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Ranibizumab Market Size Market Share by Application (2017-2022)
3 Ranibizumab Market Size by Player
3.1 Ranibizumab Market Size Market Share by Players
3.1.1 Global Ranibizumab Revenue by Players (2020-2022)
3.1.2 Global Ranibizumab Revenue Market Share by Players (2020-2022)
3.2 Global Ranibizumab Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Ranibizumab by Regions
4.1 Ranibizumab Market Size by Regions (2017-2022)
4.2 Americas Ranibizumab Market Size Growth (2017-2022)
4.3 APAC Ranibizumab Market Size Growth (2017-2022)
4.4 Europe Ranibizumab Market Size Growth (2017-2022)
4.5 Middle East & Africa Ranibizumab Market Size Growth (2017-2022)
5 Americas
5.1 Americas Ranibizumab Market Size by Country (2017-2022)
5.2 Americas Ranibizumab Market Size by Type (2017-2022)
5.3 Americas Ranibizumab Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ranibizumab Market Size by Region (2017-2022)
6.2 APAC Ranibizumab Market Size by Type (2017-2022)
6.3 APAC Ranibizumab Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Ranibizumab by Country (2017-2022)
7.2 Europe Ranibizumab Market Size by Type (2017-2022)
7.3 Europe Ranibizumab Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ranibizumab by Region (2017-2022)
8.2 Middle East & Africa Ranibizumab Market Size by Type (2017-2022)
8.3 Middle East & Africa Ranibizumab Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Ranibizumab Market Forecast
10.1 Global Ranibizumab Forecast by Regions (2023-2028)
10.1.1 Global Ranibizumab Forecast by Regions (2023-2028)
10.1.2 Americas Ranibizumab Forecast
10.1.3 APAC Ranibizumab Forecast
10.1.4 Europe Ranibizumab Forecast
10.1.5 Middle East & Africa Ranibizumab Forecast
10.2 Americas Ranibizumab Forecast by Country (2023-2028)
10.2.1 United States Ranibizumab Market Forecast
10.2.2 Canada Ranibizumab Market Forecast
10.2.3 Mexico Ranibizumab Market Forecast
10.2.4 Brazil Ranibizumab Market Forecast
10.3 APAC Ranibizumab Forecast by Region (2023-2028)
10.3.1 China Ranibizumab Market Forecast
10.3.2 Japan Ranibizumab Market Forecast
10.3.3 Korea Ranibizumab Market Forecast
10.3.4 Southeast Asia Ranibizumab Market Forecast
10.3.5 India Ranibizumab Market Forecast
10.3.6 Australia Ranibizumab Market Forecast
10.4 Europe Ranibizumab Forecast by Country (2023-2028)
10.4.1 Germany Ranibizumab Market Forecast
10.4.2 France Ranibizumab Market Forecast
10.4.3 UK Ranibizumab Market Forecast
10.4.4 Italy Ranibizumab Market Forecast
10.4.5 Russia Ranibizumab Market Forecast
10.5 Middle East & Africa Ranibizumab Forecast by Region (2023-2028)
10.5.1 Egypt Ranibizumab Market Forecast
10.5.2 South Africa Ranibizumab Market Forecast
10.5.3 Israel Ranibizumab Market Forecast
10.5.4 Turkey Ranibizumab Market Forecast
10.5.5 GCC Countries Ranibizumab Market Forecast
10.6 Global Ranibizumab Forecast by Type (2023-2028)
10.7 Global Ranibizumab Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Ranibizumab Product Offered
11.1.3 Roche Ranibizumab Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Ranibizumab Product Offered
11.2.3 Novartis Ranibizumab Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Ranibizumab Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Glass Vial
Table 3. Major Players of Prefilled Syringe
Table 4. Ranibizumab Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Ranibizumab Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Ranibizumab Market Size Market Share by Type (2017-2022)
Table 7. Ranibizumab Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Ranibizumab Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Ranibizumab Market Size Market Share by Application (2017-2022)
Table 10. Global Ranibizumab Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Ranibizumab Revenue Market Share by Player (2020-2022)
Table 12. Ranibizumab Key Players Head office and Products Offered
Table 13. Ranibizumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Ranibizumab Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Ranibizumab Market Size Market Share by Regions (2017-2022)
Table 18. Americas Ranibizumab Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Ranibizumab Market Size Market Share by Country (2017-2022)
Table 20. Americas Ranibizumab Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Ranibizumab Market Size Market Share by Type (2017-2022)
Table 22. Americas Ranibizumab Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Ranibizumab Market Size Market Share by Application (2017-2022)
Table 24. APAC Ranibizumab Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Ranibizumab Market Size Market Share by Region (2017-2022)
Table 26. APAC Ranibizumab Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Ranibizumab Market Size Market Share by Type (2017-2022)
Table 28. APAC Ranibizumab Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Ranibizumab Market Size Market Share by Application (2017-2022)
Table 30. Europe Ranibizumab Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Ranibizumab Market Size Market Share by Country (2017-2022)
Table 32. Europe Ranibizumab Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Ranibizumab Market Size Market Share by Type (2017-2022)
Table 34. Europe Ranibizumab Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Ranibizumab Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Ranibizumab Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Ranibizumab Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Ranibizumab Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Ranibizumab Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Ranibizumab Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Ranibizumab Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Ranibizumab
Table 43. Key Market Challenges & Risks of Ranibizumab
Table 44. Key Industry Trends of Ranibizumab
Table 45. Global Ranibizumab Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Ranibizumab Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Ranibizumab Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Ranibizumab Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Ranibizumab Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Ranibizumab Market Size Market Share Forecast by Application (2023-2028)
Table 51. Roche Details, Company Type, Ranibizumab Area Served and Its Competitors
Table 52. Roche Ranibizumab Product Offered
Table 53. Roche Ranibizumab Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Novartis Details, Company Type, Ranibizumab Area Served and Its Competitors
Table 57. Novartis Ranibizumab Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Ranibizumab Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis Latest Developments
List of Figures
Figure 1. Ranibizumab Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ranibizumab Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Ranibizumab Market Size Market Share by Type in 2021
Figure 7. Ranibizumab in Wet AMD
Figure 8. Global Ranibizumab Market: Wet AMD (2017-2022) & ($ Millions)
Figure 9. Ranibizumab in Complications of Diabetes
Figure 10. Global Ranibizumab Market: Complications of Diabetes (2017-2022) & ($ Millions)
Figure 11. Ranibizumab in RVO
Figure 12. Global Ranibizumab Market: RVO (2017-2022) & ($ Millions)
Figure 13. Ranibizumab in Others
Figure 14. Global Ranibizumab Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Ranibizumab Market Size Market Share by Application in 2021
Figure 16. Global Ranibizumab Revenue Market Share by Player in 2021
Figure 17. Global Ranibizumab Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Ranibizumab Market Size 2017-2022 ($ Millions)
Figure 19. APAC Ranibizumab Market Size 2017-2022 ($ Millions)
Figure 20. Europe Ranibizumab Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Ranibizumab Market Size 2017-2022 ($ Millions)
Figure 22. Americas Ranibizumab Value Market Share by Country in 2021
Figure 23. Americas Ranibizumab Consumption Market Share by Type in 2021
Figure 24. Americas Ranibizumab Market Size Market Share by Application in 2021
Figure 25. United States Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Ranibizumab Market Size Market Share by Region in 2021
Figure 30. APAC Ranibizumab Market Size Market Share by Application in 2021
Figure 31. China Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Ranibizumab Market Size Market Share by Country in 2021
Figure 38. Europe Ranibizumab Market Size Market Share by Type in 2021
Figure 39. Europe Ranibizumab Market Size Market Share by Application in 2021
Figure 40. Germany Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Ranibizumab Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Ranibizumab Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Ranibizumab Market Size Market Share by Application in 2021
Figure 48. Egypt Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Ranibizumab Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 54. APAC Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 55. Europe Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 57. United States Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 58. Canada Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 61. China Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 62. Japan Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 63. Korea Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 65. India Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 66. Australia Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 67. Germany Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 68. France Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 69. UK Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 70. Italy Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 71. Russia Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 72. Spain Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 75. Israel Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Ranibizumab Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Ranibizumab Market Size 2023-2028 ($ Millions)
